The field of pediatric cancer predisposition has been rapidly growing. This presentation will discuss the evolution of genetic testing and identification of children with cancer predisposition syndromes. Ms. Schienda will highlight the expanding phenotypes of known syndromes and will discuss the tenets of current and future surveillance programs. DICER1- syndrome will be used as a model throughout the presentation.
Level of Instruction: Intermediate